These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38979415)

  • 1. Associations between systemic inflammation indicators and nonalcoholic fatty liver disease: evidence from a prospective study.
    Gong H; He Q; Zhu L; Feng Z; Sun M; Jiang J; Yuan X; Shen Y; Di J
    Front Immunol; 2024; 15():1389967. PubMed ID: 38979415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk.
    Liu K; Tang S; Liu C; Ma J; Cao X; Yang X; Zhu Y; Chen K; Liu Y; Zhang C; Liu Y
    Front Immunol; 2024; 15():1337241. PubMed ID: 38481995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
    Zhao E; Cheng Y; Yu C; Li H; Fan X
    Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic inflammation indicators and risk of incident arrhythmias in 478,524 individuals: evidence from the UK Biobank cohort.
    Yang X; Zhao S; Wang S; Cao X; Xu Y; Yan M; Pang M; Yi F; Wang H
    BMC Med; 2023 Feb; 21(1):76. PubMed ID: 36855116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease.
    Zhao Y; Xia J; He H; Liang S; Zhang H; Gan W
    Front Endocrinol (Lausanne); 2022; 13():981196. PubMed ID: 36518239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating fatty acids and risk of severe non-alcoholic fatty liver disease in the UK biobank: a prospective cohort of 116 223 individuals.
    Zhuang P; Ao Y; Liu X; Ye H; Li H; Wan X; Zhang Y; Jiao J
    Food Funct; 2024 Oct; 15(20):10527-10538. PubMed ID: 39370886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between systemic inflammatory indicators with the survival of chronic kidney disease: a prospective study based on NHANES.
    Chen Y; Nie Y; Wu J; Li C; Zheng L; Zhu B; Min Y; Ling T; Liu X
    Front Immunol; 2024; 15():1365591. PubMed ID: 38650947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of systemic inflammatory indices with anthropometric measures, metabolic factors, and liver function in non-alcoholic fatty liver disease.
    Arefhosseini S; Aghajani T; Tutunchi H; Ebrahimi-Mameghani M
    Sci Rep; 2024 Jun; 14(1):12829. PubMed ID: 38834647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between the systemic immune inflammation index and the nonalcoholic fatty liver disease in American adolescents.
    Fu DF; Chen B
    BMC Gastroenterol; 2024 Jul; 24(1):233. PubMed ID: 39044158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants.
    Petermann-Rocha F; Wirth MD; Boonpor J; Parra-Soto S; Zhou Z; Mathers JC; Livingstone K; Forrest E; Pell JP; Ho FK; Hébert JR; Celis-Morales C
    BMC Med; 2023 Apr; 21(1):123. PubMed ID: 37013578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study.
    Fricker ZP; Pedley A; Massaro JM; Vasan RS; Hoffmann U; Benjamin EJ; Long MT
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1157-1164.e4. PubMed ID: 30476583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive role of the platelet-to-lymphocyte ratio for the risk of non-alcoholic fatty liver disease and cirrhosis: a nationwide cross-sectional study.
    Yan C; Zhang W; Xiao Y; Sun Y; Peng X; Cai W
    Front Endocrinol (Lausanne); 2024; 15():1376894. PubMed ID: 39040676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study.
    Zhang S; Gu Y; Bian S; Lu Z; Zhang Q; Liu L; Meng G; Yao Z; Wu H; Wang Y; Zhang T; Wang X; Sun S; Wang X; Zhou M; Jia Q; Song K; Qi L; Niu K
    Am J Clin Nutr; 2021 May; 113(5):1265-1274. PubMed ID: 33564868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
    J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: a cross-sectional study.
    Zhou Y; Tian N; Li P; He Y; Tong L; Xie W
    Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1158-1164. PubMed ID: 36170685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Al Rifai M; Silverman MG; Nasir K; Budoff MJ; Blankstein R; Szklo M; Katz R; Blumenthal RS; Blaha MJ
    Atherosclerosis; 2015 Apr; 239(2):629-33. PubMed ID: 25683387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.
    Liu CF; Chien LW
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
    Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
    Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.